Leukemia | Norton Healthcare

Indication: Leukemia

A First in Human Study of the Menin-KMT2A (MLL1) Inhibitor JNJ-75276617 in
Participants with Acute Leukemia

Drug Study

Principal Investigator: Don Stevens, M.D.
Norton Cancer Institute

Sponsor: Janssen Research & Development

Learn more at ClinicalTrials.gov

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.